Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility

International Journal of Cancer

Volumn 121, Issue 7, 2007, Pages 1631-1636

  Barwell, Julian ^a   Pangon, Laurent ^b   Georgiou, Anne ^b   Kesterton, Ian ^b   Langman, Caroline ^b   Arden Jones, Audrey ^c   Bancroft, Elizabeth ^c   Salmon, Ashi ^c   Locke, Imogen ^c   Kote Jarai, Zsofia ^c   Morris, Joanna R ^b   Solomon, Ellen ^b   Berg, Jonathan ^d   Docherty, Zoe ^b   Camplejohn, Richard ^e   Eeles, Rosalind ^c   Hodgson, Shirley V ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

BRCA1; BRCA2; Chromosome; Radiosensitivity

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL CYCLE S PHASE; CHROMOSOME BREAKAGE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HOMOLOGOUS RECOMBINATION; HUMAN; IRRADIATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RADIOSENSITIVITY;

ADULT; APOPTOSIS; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CELL CYCLE; CHROMOSOME BREAKAGE; FEMALE; G2 PHASE; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; KINETICS; LYMPHOCYTES; MUTATION; S PHASE; TIME FACTORS;

EID: 34548261360     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22915     Document Type: Article

References (26)

1. Steel GG. From targets to genes: a brief history of radiosensitivity. Phys Med Biol 1996;41:205-22.
2. Scott D, Spreadborough AR, Jones LA, Roberts SA, Moore CJ. Chromosomal radiosensitivity in G2-phase lymphocytes as an indicator of cancer predisposition. Radiat Res 1996;145:3-16.
3. Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundan T, Mannermaa A, Borresen-Dale AL, Borg A, Barkardottir RB, Petrini J, Winqvist R. RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability. Carcinogenesis 2006;8: 1593-9.
4. Scott D, Barber JB, Spreadborough AR, Burrill W, Roberts SA. Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 1999;75:1-10.
5. Djuzenova CS, Muhl B, Fehn M, Oppitz U, Muller B, Flentje M. Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays. Br J Cancer 2006;94:1194-203.
6. Tutt A, Ashworth A. The relationship between the roles of BRCA genes in DNA repair and cancer predisposition. Trends Mol Med 2002;8:571-6.
7. Saleh-Gohari N, Helleday T. Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells. Nucleic Acids Res 2004;32:3683-8.
8. Scully R, Livingston DM. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 2000;408:429-32.
9. Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I, Yarnold J, Evans G, Eccles D, Hodgson S, Ashley S, Ashcroft L, Tutt A, et al. Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Cancer Res 2006;12:7025-32.
10. Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I, Yarnold J, Evans G, Eccles D, Hodgson S, Ashley S, Ashcroft L, Tutt A, et al. Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom. Clin Cancer Res 2006;12:7033-8.
11. Broeks A, de Witte L, Nooijen A, Huseinovic A, Klijn JG, van Leeuwen FE, Russell NS, van't Veer LJ. Excess risk for contralateral breast cancer in CHEK2*c.1100delC germline mutation carriers. Breast Cancer Res Treat 2004;83:91-3.
12. Prysyazhnyuk A, Gristchenko V, Fedorenko Z, Gulak L, Fuzik M, Slipenyuk K, Tirmarche M. Twenty years after the Chernobyl accident: solid cancer incidence in various groups of the Ukrainian population. Radiat Environ Biophys 2007;46:43-51.
13. Baeyens A, Thierens H, Claes K, Poppe B, de Ridder L, Vral A. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol 2004;80:745-56.
14. Kotsopoulos J, Chen Z, Vallis KA, Poll A, Ainsworth P, Narod SA. DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers. Br J Cancer 2007;96:118-25.
15. Baeyens A, Van Den Broecke R, Makair A, Thierens H, De Ridder L, Vral A. Chromosomal radiosensitivity in breast cancer patients: influence of age of onset of the disease. Oncol Rep 2005;13:347-53.
16. Rothfuss A, Schutz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G. Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 2000;60:390-4.
17. Sanford KK, Parshad R, Price FM, Gantt R, Jones GM, Tarone RE. Deficient G2 phase repair of radiation-induced chromatin damage in the SENCAR mouse. Carcinogenesis 1989;10:1911-16.
18. Docherty Z, Georgiou A, Langman C, Kesterton I, Rose S, Camplejohn R, Ball J, Barwell J, Gilchrist R, Pangon L, Berg J, Hodgson S. Is chromosome radiosensitivity and apoptotic response to irradiation correlated with cancer susceptibility? Int J Radiat Biol 2007;83:1-12.
19. Camplejohn RS, Perry P, Hodgson SV, Turner G, Williams A, Upton C, MacGeoch C, Mohammed S, Barnes DM. A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. Br J Cancer 1995; 72:654-62.
20. Gilchrist R, Lomax ME, Camplejohn RS. The need for dynamic methods for measuring cell cycle perturbations: a study in radiation-treated lymphoblastoid cell lines of varying p53 status. Cell Prolif 1999; 32:15-24.
21. Camplejohn RS, Gilchrist R, Easton D, McKenzie-Edwards E, Barnes DM, Eccles DM, Ardern-Jones A, Hodgson SV, Duddy PM, Eeles RA. Apoptosis, ageing and cancer susceptibility. Br J Cancer 2003; 88487-90.
22. Paz-y-Miño C, Dávalos MV, Sánchez ME, Arévalo M, Leone PE. Should gaps be included in chromosomal aberration analysis? Mutat Res Genet Toxicol Enviro Mutagen 2002;516:57-61.
23. Bryant PE, Gray L, Riches AC, Steel CM, Finnon P, Howe O, Kesterton I, Vral A, Curwen GB, Smart V, Tawn EJ, Whitehouse CA. The G2 chromosomal radiosensitivity assay. Int J Radiat Biol 2002; 78:863-6.
24. Savage JRK. On the nature of visible of visible chromosomal gaps and breaks. Cytogenet Genome Res 2004;104:46-55.
25. Kote-Jarai Z, Salmon A, Mengitsu T, Copeland M, Ardern-Jones A, Locke I, Shanley S, Summersgill B, Lu YJ, Shipley J, Eeles R. Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. Br J Cancer 2006;94:308-10.
26. McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O'connor MJ, Tutt AN, Zdzienicka MZ, Smith GC, Ashworth A. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to Poly(ADP-Ribose) polymerase inhibition. Cancer Res 2006;66:8109-15.